Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says (updated)

Mitsubishi Chemical

20/01/2025 10:24

(Adds the expected sales price)
       TOKYO, Jan 20 (Reuters) - Mitsubishi Chemical Group  4188.T  has given
the U.S. investment fund Bain Capital the right of first refusal to negotiate
the purchase of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the
Nikkei reported on Monday.
    Mitsubishi Chemical is likely to sell Tanabe Mitsubishi Pharma to Bain
Capital for more than 500 billion yen, the report said.
        
  
    

 (Reporting by Kaori Kaneko; Editing by Toby Chopra)
 ((kaori.kaneko@thomsonreuters.com;))